Fund Holdings — SECTOR GAMMA AS

Total Portfolio Value:
$460.97M
Total Bought:
$110.21M
Total Sold:
$81.17M
Net Transaction:
+$29.04M
Securities
▲▼
SharesValue
Q1 2026
▲▼
Q2 2026
▲▼
Change
▲▼
Q1 2026
▲▼
Q2 2026
▲▼
Weight (%)
▲▼
Change
▲▼
Bristol-Myers Squibb Company(BMY)827,901726,115-101,786$50.21M$41.84M9.08%-$8.37M
Merck & Co., Inc.(MRK)260,340217,008-43,332$31.32M$27.89M6.05%-$3.43M
Medtronic plcSHS(MDT)280,682352,437+71,755$24.32M$27.57M5.98%+$3.25M
Pfizer Inc.(PFE)1,091,3851,004,215-87,170$30.65M$24.18M5.25%-$6.46M
Incyte Corporation(INCY)200,510170,753-29,757$18.87M$19.36M4.20%+$484.6K
Elevance Health, Inc.(ELV)43,96244,499+537$12.87M$17.21M3.73%+$4.34M
BioMarin Pharmaceutical Inc.(BMRN)239,918294,918+55,000$13.55M$16.88M3.66%+$3.32M
Thermo Fisher Scientific Inc.(TMO)033,584+33,584$0$16.84M3.65%+$16.84M
CVS Health Corporation(CVS)135,337155,337+20,000$9.72M$16.07M3.49%+$6.35M
IQVIA Holdings Inc.(IQV)40,23077,944+37,714$6.86M$15.06M3.27%+$8.20M
Ionis Pharmaceuticals, Inc.(IONS)169,468189,468+20,000$12.73M$15.02M3.26%+$2.30M
Becton, Dickinson and Company(BDX)82,61593,168+10,553$12.99M$14.10M3.06%+$1.11M
Abbott Labs87,532147,444+59,912$8.99M$13.38M2.90%+$4.39M
GE HealthCare Technologies Inc.(GEHC)126,418207,863+81,445$9.00M$13.31M2.89%+$4.31M
Zimmer Biomet Holdings, Inc.(ZBH)155,835142,307-13,528$14.09M$12.25M2.66%-$1.84M
Biogen Inc.(BIIB)90,09654,163-35,933$16.52M$11.70M2.54%-$4.81M
Qiagen N.V.(QGEN)162,371287,640+125,269$6.50M$11.25M2.44%+$4.75M
Centene Corporation(CNC)162,405162,4050$5.32M$10.42M2.26%+$5.11M
Regeneron Pharmaceuticals, Inc.(REGN)015,780+15,780$0$9.84M2.13%+$9.84M
Bio Rad Labs IncCL A23,75033,350+9,600$6.62M$9.79M2.12%+$3.17M
Cardinal Health, Inc.(CAH)54,89740,689-14,208$11.60M$9.67M2.10%-$1.93M
Amgen Inc.(AMGN)47,15526,281-20,874$16.59M$9.52M2.06%-$7.07M
Bruker Corporation(BRKR)254,010152,352-101,658$9.17M$9.17M1.99%-$6.3K
Avantor, Inc.(AVTR)695,403906,088+210,685$5.45M$8.97M1.95%+$3.52M
PTC Therapeutics, Inc.(PTCT)75,000100,000+25,000$5.11M$8.16M1.77%+$3.05M
Labcorp Holdings Inc.(LH)19,01926,019+7,000$5.07M$7.29M1.58%+$2.21M
DexCom, Inc.(DXCM)56,122102,122+46,000$3.52M$6.88M1.49%+$3.35M
Ascendis Pharma A/S(ASND)021,305+21,305$0$5.68M1.23%+$5.68M
Edwards Lifesciences Corp60,40260,4020$4.84M$5.46M1.19%+$627.0K
Syndax Pharmaceuticals, Inc.(SNDX)286,007241,739-44,268$6.68M$5.28M1.15%-$1.40M
Boston Scientific Corporation(BSX)0121,128+121,128$0$5.17M1.12%+$5.17M
Kura Oncology, Inc.(KURA)411,810433,012+21,202$3.35M$4.75M1.03%+$1.40M
Travere Therapeutics, Inc.(TVTX)080,000+80,000$0$4.54M0.99%+$4.54M
Crinetics Pharmaceuticals In94,195114,628+20,433$3.42M$4.29M0.93%+$868.2K
Tandem Diabetes Care, Inc.(TNDM)267,091267,0910$5.12M$4.03M0.87%-$1.09M
Iovance Biotherapeutics, Inc.(IOVA)900,000968,466+68,466$3.16M$4.03M0.87%+$869.8K
Cytokinetics, Incorporated(CYTK)045,000+45,000$0$3.83M0.83%+$3.83M
Organon & Co.(OGN)375,974270,781-105,193$2.25M$3.67M0.80%+$1.41M
Ardelyx Inc516,131686,844+170,713$3.09M$3.50M0.76%+$411.3K
Intellia Therapeutics, Inc.(NTLA)0185,177+185,177$0$3.13M0.68%+$3.13M
Arrowhead Pharmaceuticals, Inc.(ARWR)30,0000-30,000$1.88M$0—-$1.88M
Ascendis Pharma A/SADR(ASND)21,3050-21,305$4.87M$0—-$4.87M
BridgeBio Pharma, Inc.(BBIO)44,2630-44,263$3.29M$0—-$3.29M
Cogent Biosciences, Inc.(COGT)80,0000-80,000$3.08M$0—-$3.08M
Denali Therapeutics Inc.(DNLI)162,7100-162,710$3.12M$0—-$3.12M
Gilead Sciences, Inc.(GILD)53,2470-53,247$7.42M$0—-$7.42M
Humana Inc.(HUM)19,2020-19,202$3.33M$0—-$3.33M
Lantheus Holdings, Inc.(LNTH)93,3440-93,344$7.08M$0—-$7.08M
UnitedHealth Group Incorporated(UNH)36,4350-36,435$9.86M$0—-$9.86M
Page 1 of 1
SECTOR GAMMA AS — 13F Holdings — Q2 2026 | TickerTrail